Biolife stock.

1. Organization and significant accounting policies Business BioLife Solutions, Inc. (“BioLife”, “us”, “we”, “our”, or the “Company”) is a developer, manufacturer, and supplier of a portfolio of bioproduction tools and services including proprietary biopreservation media, automated cell processing fill machines, closed system cryogenic …WebBioLife Solutions Reports First Quarter 2023 Financial Results. Revenue of $37.7 million increased 4% over Q1 2022, ex-COVID growth of 16% and biopreservation media revenue growth of 28%. Q1 2023 ...Notes to Financial Statements Business Combination Disclosure [Text Block] 3. Acquisitions Sexton acquisition General terms and effects On August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation (“Sexton Merger Sub”), Fortis Advisors LLC, in its capacity …Complete BioLife Solutions Inc. stock information by Barron's. View real-time BLFS stock price and news, along with industry-best analysis. SciSafe had 2019 unaudited revenue of $6 million and positive EBITDA and is anticipated to be accretive during 2021.. Under the terms of the agreement, BioLife will pay $15 million in cash and $15 million in newly issued shares of BioLife common stock for 100% of the outstanding shares of SciSafe. SciSafe's shareholders are also eligible over …Web

Dec 1, 2023 · BioLife Solutions (NASDAQ:BLFS) and Zynex (NASDAQ:ZYXI) are both small-cap medical companies, but which is the superior stock?We will contrast the two companies based on the strength of their dividends, risk, earnings, profitability, valuation, analyst recommendations, institutional ownership, media sentiment and community ranking. BioLife Solutions Trading Up 2.5 %. NASDAQ BLFS traded up $0.33 on Monday, hitting $13.58. 44,504 shares of the stock were exchanged, compared to its average volume of 403,529. The company’s 50 ...WebChg %. Market Cap. Evogene Ltd. -1.07%. $30.17M. BLFS | Complete BioLife Solutions Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial...

BioLife will issue 6,646,870 shares of common stock for 100% of the outstanding shares of Stirling in an all-stock transaction, which is expected to close early in the second quarter of 2021. With Stirling, BioLife believes that total GAAP revenue in 2021 will exceed $100 million and the transaction is expected to be accretive on an adjusted ...Nasdaq -23.34(-0.16%) Russell 2000 +10.01 BioLife Solutions, Inc. (BLFS) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 14.14 +0.57 (+4.20%) …

BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …BioLife Solutions is trading near 52-week lows as its growth story has floundered and profitability remains uncertain. Learn why I rate BLFS stock a hold.WebBioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. BioLife Solutions Stock Performance. BLFS stock opened at $14.08 on Monday. The business has a 50 day moving average of $12.13 and a 200-day moving average of $16.47. BioLife Solutions, Inc. has a 12-month low of $8.92 and a 12-month high of $26.89. The firm has a market cap of $619.96 million, a PE ratio of -5.94 and a beta of 1.57.Jan 6, 2023 · The stock seems fairly valued at the moment according to my valuation model. It’s trading around 20% below my intrinsic value, which means if you buy BioLife Solutions today, you’d be paying a ...

BioLife Solutions, Inc. | 6,162 followers on LinkedIn. A leading developer and supplier of class-defining bioproduction products and services for cell and gene therapies | BioLife Solutions is a ...

Octapharma to present new clinical and scientific data at ASH 2023 from ongoing research initiatives aimed at advancing care for people living with bleeding disorders

Biolife Solutions releases figures for Q3 on November 9. Wall Street analysts predict losses per share of $0.364. Go here to track Biolife Solutions stock price in real-time ahead of earnings.Roderick de Greef appointed Chairman and Chief Executive Officer bringing 20+ years of prior BioLife experience. Garrie Richardson appointed Chief Revenue Officer. Preliminary Q3 revenue of $33.3 million and expect 2023 revenue at the low end of the previously announced guidance range . BOTHELL, Wash., Oct. 19, 2023 /PRNewswire/ - …WebNov 9, 2023 · BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets. Open a brokerage account and deposit funds in it to purchase stock in a company, explains the Wall Street Journal. Companies such as Charles Schwab, E-Trade, and Ameritrade provide brokerage services.A free inside look at Biolife Plasma Services hourly pay trends based on 2096 hourly pay wages for 270 jobs at Biolife Plasma Services. Hourly Pay posted anonymously by Biolife Plasma Services employees. ... stock bonuses, profit sharing, sales commissions, and tips. Our model gets smarter over time as more people share salaries …BOTHELL, Wash., Nov. 9, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapy (CGT) and the broader biopharma markets, today announced financial results for the three and nine months …Web

Get the latest stock price for Biolife Sciences Inc (BLFE:US), plus the latest news, recent trades, charting, insider activity, and analyst ratings.Rhumbline Advisers decreased its holdings in BioLife Solutions, Inc. (NASDAQ:BLFS – Free Report) by 8.1% in the second quarter, Holdings Channel.com reports. The institutional investor owned 80,251 shares of the medical equipment provider’s stock after selling 7,097 shares during the period. Rhumbline Advisers’ holdings in BioLife Solutions were worth $1,774,000 as of its most recent […]Biolife Sciences Inc (BLFE) 0 Add to Watchlist Add to Portfolio Quotes Summary Real-Time Key Data Bid Price and Ask Price The bid & ask refers to the price …Wall Street Stock Market & Finance report, prediction for the future: You'll find the Biolife Solutions share forecasts, stock quote and buy / sell signals below. According to present data Biolife Solutions's BLFS shares and potentially its market environment have been in bearish cycle last 12 months (if exists).At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to ...

The estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.

0001354488-12-003014.txt : 20120601 0001354488-12-003014.hdr.sgml : 20120601 20120601150827 accession number: 0001354488-12-003014 conformed submission type: 8-k public document count: 2 conformed period of report: 20120530 item information: entry into a material definitive agreement item information: other events item information: financial …BioLife Sciences Inc. (BLFE.) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock BioLife Sciences Inc. | OTC Markets: BLFE ...BioLife Solutions is a bioproduction company that develops, manufactures, and sells biopreservation media, thawing products, and shipping containers for cell and gene …You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.The estimated net worth of Troy Wichterman is at least $861,719.60 as of November 13th, 2023. Mr. Wichterman owns 67,480 shares of BioLife Solutions stock worth more than $861,720 as of November 18th. This net worth estimate does not reflect any other investments that Mr. Wichterman may own.See BioLife Solutions, Inc. (BLFS) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades.In today’s fast-paced world, maintaining a healthy lifestyle can be challenging. However, thanks to technological advancements, we now have access to various tools and applications that can help us track our nutritional intake and make info...

Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to help you make ...

If you’re looking to donate plasma, Biolife Plasma Centers are a fantastic option. They offer convenient locations, a streamlined donation process, and compensation for your time. In this comprehensive guide, we’ll cover everything you need...

Fiscal Q3 2023 ended 9/30/23. Reported on 11/9/23. Get the latest BioLife Solutions Inc (BLFS) real-time quote, historical performance, charts, and other financial information to …The estimated net worth of Aby J. Mathew is at least $3.52 million as of November 13th, 2023. Dr. Mathew owns 275,726 shares of BioLife Solutions stock worth more than $3,521,021 as of November 18th. This net worth estimate does not reflect any other assets that Dr. Mathew may own.Get the latest BioLife Solutions, Inc. (BLFS) stock quote, history, news and other vital information to help you with your stock trading and investing. See the company's performance outlook, earnings date, dividend and yield, fair value, ratings and more. Wall Street Stock Market & Finance report, prediction for the future: You'll find the BioLife Sciences share forecasts, stock quote and buy / sell signals below. According to present data BioLife Sciences's BLFE shares and potentially its market environment have been in bearish cycle last 12 months (if exists). BioLife Solutions, Inc. (BLFS) has a market cap of $580592835 and a live price of $13.35. Check more stats and compare it to other stocks and crypto.Nov 30, 2023 · No changes to the price of Biolife Sciences Inc stock on the last trading day (Thursday, 30th Nov 2023). During the last trading day the stock fluctuated 100.00% from a day low at $0.0001 to a day high of $0.0002. The price has risen in 4 of the last 10 days and is up by 14900% over the past 2 weeks. BioLife Sciences is a commercialization accelerator, licensor and developer of innovative and disruptive technologies for the healthcare, beauty and food and ...View the latest BioLife Sciences Inc. (BLFE) stock price, news, historical charts, analyst ratings and financial information from WSJ. BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …Dec 18, 2022 · Conestoga Capital Advisors highlighted stocks like BioLife Solutions, Inc. (NASDAQ:BLFS) in its Q3 2022 investor letter. Headquartered in Bothell, Washington, BioLife Solutions, Inc. (NASDAQ:BLFS ...

- USA Stock USD 12.86 0.77 6.37% Given the investment horizon of 90 days and your slightly conservative level of risk, our recommendation regarding Biolife Solutions is 'Hold'BioLife Solutions Inc stock performance at a glance. Check BioLife Solutions Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.BioLife shares outstanding (as of March 19, 2021) 33,401,359 Merger consideration percentage 19.9 % Merger consideration shares 6,646,870 less: Merger consideration shares withheld to satisfy outstanding GCI stockholder obligations to GCI 10,400 Subtotal 6,636,470 BioLife stock price (as of May 3, 2021) $ 35.07 Value of issued shares $ …Nov 8, 2023 · Biolife Solutions stock has received a consensus rating of buy. The average rating score is and is based on 8 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Biolife ... Instagram:https://instagram. state street sharecrypto ira companye trade transfer stock to another personteslas news Biolife Keto Gummies helps in boosting your immunity and digestion power and makes you becomes healthy and fit in short period of time. Thursday, Nov 30, 2023 LoginBioLife Solutions, Inc. (NASDAQ:BLFS) Q3 2023 Earnings Call Transcript November 9, 2023 BioLife Solutions, Inc. beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.38 ... barrons appliancesbest forex brokers in usa for beginners BioLife Solutions, Inc. is a life sciences company. The Company develops, manufactures, and markets bioproduction tools and services which are designed to de-risk biologic manufacturing, storage, distribution, and transportation in the cell and gene therapy (CGT) industry and broader biopharma markets.WebOn August 9, 2021, BioLife entered into an Agreement and Plan of Merger (the “Sexton Merger Agreement”) with BLFS Merger Sub, Inc., a Delaware corporation ... As consideration for the Sexton Merger (the “Sexton Merger Consideration”), holders of common stock, preferred stock and options of Sexton, other than the Company … free day trading app Aug 30, 2021 · 1) Consists of 10,735,334 shares of common stock being registered for resale by selling stockholders. The shares consist of (i) 611,683 shares issued in October 2020 in connection with the registrant’s acquisition of SciSafe Holdings, Inc., which had not been previously registered, (ii) 2,956,679 shares held by Casdin Partners Master Fund, LP (“Casdin”) which were acquired in various ... The agreement calls for the issuance of 35.7 million Rhino Novi shares to BioLife's current shareholders, the cancelation of 25 million shares held by current Rhino Novi shareholders, and transactional expenses for up to CAD 0.05 million, in exchange for 100% of the shares of BioLife. BioLife,will become a wholly-owned subsidiary of Rhino …Web